Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Dusa completes phase IIb for ALA PDT

Aug. 23, 1996

Dyad granted U.S. patent for oligonucleotides

Aug. 23, 1996

Protein Polymer Technologies and Ethicon sign R&D agreement

Aug. 23, 1996

Microsponge retinol system to be codeveloped by APS and Avon

Aug. 16, 1996

Phytopharm files for U.K. marketing approval of Zemaphyte

Aug. 16, 1996

Psoriasin role in psoriasis pathology under scrutiny

Aug. 16, 1996

FK-506: A safe and effective atopic dermatitis treatment

Aug. 9, 1996

Celley issued patent for physiologic lipid mixture from Australian authorities

Aug. 9, 1996

Johnson & Johnson files patent infringement complaint against Penederm

Aug. 9, 1996

Kaken submits NDA for Fiblast in Japan

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...